Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Orchid Pharma bags USFDA nod for Enmetazobactam

Written By Ruchika Sharma24 Feb 2024 1:30 PM IST

This New Drug Approval allows the use of Exblifep (Cefepime and Enmetazobactam) as an injection for the treatment of patients 18 years and older with...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

USFDA completes inspections at Suven Pharma facilities with no form 483

Written By Ruchika Sharma24 Feb 2024 11:45 AM IST

Hyderabad: Suven Pharma has announced that the US Food & Drug Administration (US FDA) has completed the inspections at the Company's...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Dupixent application accepted for priority review by USFDA for COPD with type 2 inflammation

Written By Ruchika Sharma23 Feb 2024 4:30 PM IST

Paris: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...

No False Advertising Found: US Court Rejects Bayer Plea to Block Erleada Ads

Bayer begins Phase II study with anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis

Written By Ruchika Sharma23 Feb 2024 2:30 PM IST

Berlin: Bayer has announced the start of a Phase II clinical trial (SIRIUS study) with BAY3018250, an investigational first-in-class anti-alpha2...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

AstraZeneca completes acquisition of Gracell Biotechnologies

Written By Ruchika Sharma23 Feb 2024 12:30 PM IST

Gracell will operate as a wholly owned subsidiary of AstraZeneca, with operations in China and the US.

Novavax settles dispute with Gavi

Written By Ruchika Sharma23 Feb 2024 11:30 AM IST

Novavax has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over...

Cipla Gets 2 USFDA Observations for Goa Facility

Cipla, Dr Reddys and other Indian Pharma companies now in race to develop Wegovy versions

Written By Ruchika Sharma22 Feb 2024 2:27 PM IST

"Dr Reddy's and Cipla are making a copy of the innovator drug more like a generic version, while Sun is working on its own innovator drug. So, Sun...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

USFDA accepts for priority review Bristol Myers Squibb application for Krazati, cetuximab combo for colorectal cancer

Written By Ruchika Sharma22 Feb 2024 1:30 PM IST

New York: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Merck application for Keytruda plus chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma accepted by USFDA for priority review

Written By Ruchika Sharma22 Feb 2024 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

Britain health regulator revokes conditional marketing authorisation for Novartis sickle cell drug Adakveo

Written By Ruchika Sharma22 Feb 2024 11:20 AM IST

Sickle cell disease is a genetic disorder in which misshapen blood cells cause strokes, organ damage, severe pain and early death.

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic raises annual profit forecast on strong demand for heart devices

Written By Ruchika Sharma22 Feb 2024 9:00 AM IST

Medtronic also said it has decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions...

Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal

Sun Pharma to buy 16.33 percent stake in Surgimatix for over Rs 25 crore

Written By Ruchika Sharma21 Feb 2024 3:21 PM IST

New Delhi: Pharma major, Sun Pharmaceutical Industries Ltd, on Tuesday said it will acquire a 16.33 per cent stake in Surgimatix, Inc, a US-based firm...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok